Trials / Sponsors / Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy Participants Healthy | Phase 1 | 2025-02-19 |
| Recruiting | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease Inflammatory Bowel Diseases, Crohn's Disease | Phase 2 | 2024-07-18 |
| Active Not Recruiting | A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC Inflammatory Bowel Diseases, Colitis, Ulcerative | Phase 2 | 2022-11-21 |
| Completed | A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC Inflammatory Bowel Diseases, Colitis, Ulcerative | Phase 2 | 2022-04-13 |
| Completed | Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers Healthy Volunteers | Phase 1 | 2020-09-23 |